What are the diagnostic features of pre-eclampsia and eclampsia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis of Pre-eclampsia and Eclampsia

Pre-eclampsia is diagnosed by new-onset hypertension (≥140/90 mmHg) occurring after 20 weeks of gestation combined with either proteinuria (≥300 mg/24h) OR evidence of maternal organ dysfunction, while eclampsia is defined as the occurrence of seizures in a woman with pre-eclampsia. 1, 2, 3

Core Diagnostic Criteria for Pre-eclampsia

Blood Pressure Requirements

  • Systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg confirmed on two separate occasions at least 15 minutes apart 2
  • For severe hypertension (≥160/110 mmHg), confirmation should occur within 15 minutes 2
  • Hypertension must be new-onset after 20 weeks of gestation in previously normotensive women 1, 2, 3
  • Blood pressure measurement technique is critical, as errors have been implicated in maternal deaths 1

Proteinuria Assessment

  • Significant proteinuria is defined as >0.3 g/24h or albumin-creatinine ratio ≥30 mg/mmol 2
  • Dipstick testing ≥1+ should prompt immediate quantitative evaluation using albumin-creatinine ratio or 24-hour urine collection 2
  • An albumin-creatinine ratio <30 mg/mmol reliably excludes proteinuria 2
  • Proteinuria is present in only 75% of pre-eclampsia cases and is no longer required for diagnosis 2, 3

Alternative Diagnostic Criteria (When Proteinuria Absent)

When proteinuria is absent, pre-eclampsia can be diagnosed if gestational hypertension is accompanied by any one of the following maternal organ dysfunctions 2:

Renal dysfunction:

  • Serum creatinine ≥1.1 mg/dL or doubling of baseline creatinine 2

Hepatic dysfunction:

  • Elevated liver transaminases ≥2 times upper limit of normal 2, 3
  • Persistent epigastric or right upper quadrant pain 3

Hematological dysfunction:

  • Thrombocytopenia <100,000/microliter 2, 3

Neurological complications:

  • Severe headache unresponsive to medication 1, 2
  • Visual disturbances (scotomata, photophobia, blurred vision) 1, 2, 3
  • Altered mental status 2

Pulmonary complications:

  • Pulmonary edema 2, 3

Uteroplacental dysfunction:

  • Fetal growth restriction 2
  • Abnormal umbilical artery Doppler waveform analysis 2
  • Reduced fetal movements 1
  • Intrauterine fetal death 2

Eclampsia Diagnosis

Eclampsia is diagnosed when seizures occur in a woman with pre-eclampsia, typically presenting as generalized tonic-clonic convulsions 3, 4

Timing of Eclamptic Seizures

  • 44% occur postnatally 4
  • 38% occur antepartum 4
  • 18% occur intrapartum 4
  • Eclampsia is most common at term (≥37 weeks' gestation) 5

Screening and Assessment Protocol

Initial Risk Assessment (Before 20 Weeks)

Identify women with any of the following predisposing factors 1:

  • First pregnancy (nulliparity) - RR 2.91 1, 5
  • Previous pre-eclampsia - RR 7.19 1, 5
  • ≥10 years since last baby 1
  • Age ≥40 years - RR 1.68-1.96 1, 5
  • Body mass index ≥35 - RR 1.55 1, 5
  • Family history of pre-eclampsia (mother or sister) - RR 2.90 1, 5
  • Booking diastolic blood pressure ≥80 mmHg 1
  • Proteinuria at booking (≥+ on more than one occasion or ≥300 mg/24h) 1
  • Multiple pregnancy - RR 2.93 1, 5
  • Pre-existing diabetes - RR 3.56 1, 5
  • Pre-existing hypertension or renal disease 1
  • Presence of antiphospholipid antibodies - RR 9.72 1, 5

Monitoring After 20 Weeks

At every antenatal assessment, screen for the following signs and symptoms 1, 2:

  • New hypertension (BP ≥140/90 mmHg) 1
  • New proteinuria (≥+ on dipstick) 1
  • Headache or visual disturbances 1
  • Epigastric pain or vomiting 1
  • Reduced fetal movements or small for gestational age infant 1

Monitoring Frequency

  • Women with one risk factor: assess at least every 3 weeks before 32 weeks, then every 2 weeks until delivery 1, 5
  • Women with no risk factors: follow standard antenatal protocols but educate about symptoms 1, 5
  • Pre-eclampsia can progress to life-threatening status within approximately 2 weeks of diagnosis 1, 5, 2

Laboratory Evaluation

When pre-eclampsia is suspected, obtain 2:

  • Complete blood count (assess for thrombocytopenia) 2
  • Liver enzymes (AST, ALT) 2
  • Serum creatinine and electrolytes 2
  • Uric acid 2
  • Urinalysis with protein quantification 2

Biomarker for Risk Stratification

  • sFlt-1/PlGF ratio ≤38 can exclude development of pre-eclampsia in the following week when clinically suspected 2

Severity Classification

Pre-eclampsia with severe features includes 2, 3:

  • Severe hypertension (≥160/110 mmHg) despite treatment with multiple antihypertensives 2
  • Progressive thrombocytopenia (<100,000/μL) 2, 3
  • Progressive abnormal renal function tests 2
  • Progressive abnormal liver enzyme tests 2
  • Pulmonary edema 2, 3
  • Neurological complications (persistent headache, visual disturbances) 2, 3
  • HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) 3
  • Non-reassuring fetal status 2

Referral Thresholds from Community Settings

New Hypertension Without Proteinuria

  • Diastolic BP ≥90 and <100 mmHg: refer for hospital assessment within 48 hours 1, 2
  • Diastolic BP ≥90 and <100 mmHg WITH any symptoms: refer for same-day hospital assessment 1
  • Diastolic BP ≥100 mmHg OR systolic BP ≥160 mmHg: refer for same-day hospital assessment 2

New Hypertension With Proteinuria

  • Diastolic BP ≥90 mmHg with proteinuria ≥+ on dipstick: refer for same-day hospital assessment 2
  • Diastolic BP ≥110 mmHg OR systolic BP ≥170 mmHg with proteinuria: arrange immediate admission 2

Postpartum Pre-eclampsia Diagnosis

Postpartum pre-eclampsia is diagnosed by new-onset hypertension (≥140/90 mmHg) occurring 48 hours to 6 weeks after delivery with either proteinuria or maternal organ dysfunction 6

Postpartum Monitoring Protocol

  • Measure blood pressure at least every 4 hours while awake for at least 3 days postpartum 6
  • Perform urinalysis if hypertension detected 6
  • Screen for symptoms: headache, visual disturbances, epigastric pain, nausea/vomiting 6
  • Review all women with postpartum pre-eclampsia at 3 months to ensure normalization 6

Critical Pitfalls to Avoid

  • Do not classify pre-eclampsia as "mild" versus "severe" clinically - all cases may rapidly progress to emergencies 5
  • Blood pressure alone is not reliable for risk stratification - serious organ dysfunction can develop at relatively mild hypertension levels 5
  • Do not use serum uric acid or proteinuria levels as indications for delivery 2
  • Do not rely on hyperreflexia - this is a nonspecific finding in healthy young women and no longer recommended as diagnostic criterion 2
  • Absence of antenatal care is strongly associated with eclampsia and fetal death 5
  • Women with no risk factors can still develop pre-eclampsia - maintain vigilance in all pregnancies 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Preeclampsia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Preeclampsia: an update.

Acta anaesthesiologica Belgica, 2014

Research

[Preeclampsia and eclampsia].

Medicina (Kaunas, Lithuania), 2003

Guideline

Preeclampsia Risk and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing Postpartum Preeclampsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.